Cipla Ltd reported a robust 30% YoY increase in consolidated net profit, reaching Rs 1,222 crore for Q4 FY25, driven by strong sales in India, the US, and Africa. For the full fiscal year, net ...

Cipla, India's third-biggest drugmaker by sales, reported a fourth-quarter profit that beat estimates on Tuesday (May 13, 2025), helped by strong demand for its drugs used to treat chronic ...

Cipla is facing moderate headwinds at the moment. India business underwent a soft two quarters, US business faced supply issues in one main product and Trump tariff pressure has impacted the ...

"Formosa Pharma welcomes this partnership with Cipla, a well-renowned and respected global pharmaceutical brand. We appreciate their recognition and desire to add APP13007 to their rich portfolio ...

Cipla shares gained over 2 percent on December 17 after Kotak Institutional Equities upgraded the stock to a 'buy' from its previous 'add' rating. The upgrade was driven by factors such as ...

Drugmaker Cipla has got regulatory approval to market Afrezza, a rapid acting insulin delivered through an inhaler, as compared to other insulins given through injections. The Central Drugs ...

Cipla share price fell the most in terms of percentage among all the 50 companies in the NSE Nifty today Cipla share price: Cipla Ltd shares fell the most in terms of percentage among all the 50 ...

Drugmaker Cipla continues to struggle with regulatory challenges which have caused delays in the launch of two key drugs--respiratory medication Advair and chemotherapy drug Abraxane- yet again.

Oct 29 (Reuters) - Cipla (CIPL.NS), opens new tab, India's third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, driven by higher sales of ...

Our mission at Long Island Business News is to be the vital business news and advertising source to Long Island’s most influential readers.

Omnigel, from Cipla Health, has announced the launch of its new campaign "Aapki Khushi Ko Dard Ki Nazar Na Lage”. Omnigel’s new campaign film takes a refreshingly authentic approach to pain care.

Cipla has received the Food and Drug Administration’s blessing for lanreotide injection 120 mg/0.5 ml, 90 mg/0.3 ml, 60 mg/0.2 ml, which is the generic of somatuline depot (lanreotide) injection ...